Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Net Shares Issued and Repurchased (2011 - 2026)

Nuwellis' (NUWE) quarterly Net Shares Issued and Repurchased came in at $768.0 in Q2 2026, up 529.51% on a YoY basis from $122.0 in Q2 2025, and up 12700.0% quarter-over-quarter from $6.0 in Q1 2026.

Analysis

Nuwellis (NUWE) Net Shares Issued and Repurchased (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Net Shares Issued and Repurchased for 16 consecutive years, with $768.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Shares Issued and Repurchased rose 529.51% year-over-year to $768.0; the trailing twelve-month figure through Jun 2026 stood at $768.0 (up 529.51% YoY), and the FY2025 full-year result was $4409.0, up 15646.43% from the prior year.
  • Net Shares Issued and Repurchased grew to $768.0 in Q2 2026 per NUWE's latest filing, from $6.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $95113.0 in Q1 2023 and bottomed at $6.0 in Q1 2026.
  • Historically, Net Shares Issued and Repurchased has averaged $7552.9 across 5 years, with a median of $595.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased plunged 99.22% in 2024, then jumped 15646.43% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $5833.0 in 2022, then plunged by 38.45% to $3590.0 in 2023, then slumped by 99.22% to $28.0 in 2024, then surged by 15646.43% to $4409.0 in 2025, then plunged by 82.58% to $768.0 in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $768.0, $6.0, and $4409.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn 768.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 768.00
Mar 31, 2026 6.00
Dec 31, 2025 4,409.00
Sep 30, 2025 18.00
Jun 30, 2025 122.00
Mar 31, 2025 12.00
Dec 31, 2024 28.00
Mar 31, 2024 1,263.00
Dec 31, 2023 3,590.00
Sep 30, 2023 595.00
Jun 30, 2023 267.00
Mar 31, 2023 95,113.00
Dec 31, 2022 5,833.00
Sep 30, 2022 369.00
Jun 30, 2022 900.00
Dec 31, 2021 9,081.00
Dec 31, 2020 5,542.00
Dec 31, 2019 9,374.00
Dec 31, 2018 163,997.00
Dec 31, 2017 2,461.00